Collectively, the identification of the genes with which BNC2 is co-expressed in cancer patients (Fig 3, “red” module), and the matrisomal genes whose expression is affected by BNC2 perturbation (Fig 4), indicate that BNC2 may serve as a novel regulator of ECM composition and processing. This evidence concerns the gene BNC2 and cancer.